What we do here has a profound impact on patients’ lives, and the values that we have are exemplified in how we work every day. Our core cultural commitments, our commitment to life, integrity, innovation, and teamwork/Wa, we have a really long history of innovation and we also have a commitment to each other where the group is greater than the self.
And I think the beauty of the Japanese culture, it brings that harmony together while at the same time allowing us to innovate on behalf of patients.
I think the other thing that's really nice about Kyowa Kirin is that most of the products that we have right now are relatively young in their life cycle.
And so we have a tremendous opportunity to not only innovate and bring new things to market, but also grow the things that we have.
I've had the opportunity since I've been here to meet with a number of patients in different therapeutic areas and, and what always strikes me is how long it took them to get the right diagnosis, how long it took them to get the right therapy.
I would like them to know, one, that we're incredibly committed to them and making their life better through our therapies to the degree to which we can.
I'd also like them to know that we fully support the patient communities which they're a part of.
The third thing would be letting them know that we are absolutely committed to helping patients like them get through their diagnostic journey into treatment faster.
I think there's unlimited potential within North America. We have a tremendous baseline portfolio that is young in its life cycle and it's growing incredibly rapidly.
We are the fastest growing region within Kyowa Kirin.
We have just announced a business development deal again with a company that has an ability to absolutely change lives if not fundamentally alter the course of very serious disease.
So as I think about what the future of Kyowa Kirin North America is, I think for those that are here, it's our story to write.
And I think that's a very unique opportunity when you're part of a pharmaceutical company.